Latest Breaking News On - Good clinical laboratory practices - Page 2 : comparemela.com

MINNEAPOLIS, April 15, 2021 /PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne brand, completed an extensive rebranding effort in response to increased demand for its Assay Services offered at its Newark, CA laboratory. At the heart of this re-launch is a name change from Pharma Assay Services to Professional Assay Services, with an expansion of offerings to global academic and clinical institutions, building on 10 years of experience providing services to our global pharma and biotech partners. Bio-Techne s Professional Assay Services provide in situ hybridization (ISH) gene expression analysis for target discovery, biomarker validation, drug safety assessment, and assay prototype development directly from the RNAscope™ technology experts.

Kim keldermanDavid clairPrnewswire bio techne corporationAssay servicesInvestor relations corporate developmentGood clinical laboratory practicesWorld health organizationPharma assay services to professionalBio techne corporationTechne corporationAdvanced cell diagnosticsPharma assay servicesProfessional assay servicesWorld healthSenior directorInvestor relations